ArticleScientific reports2025
Association between magnesium depletion score and overactive bladder among U.S. Adults using data from NHANES 2005-2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overactive bladder (OAB) is a common condition that significantly affects quality of life. Magnesium deficiency may influence muscle and nerve functions, potentially contributing to bladder dysfunction. This study aimed to examine whether magnesium depletion is associated with OAB symptoms among U.S. adults. We analyzed data from 28,621 participants aged 20-80 years in the National Health and Nutrition Examination Survey (NHANES) 2005-2018. OAB symptoms were assessed using a standardized questionnaire, and magnesium depletion was evaluated using a magnesium depletion score (MgDS). Logistic regression models adjusted for demographic, lifestyle, and clinical factors were employed to explore the association. Higher MgDS was significantly associated with an increased risk of OAB. In the fully adjusted model, each one-point increase in MgDS was linked to 9% higher odds of OAB (OR = 1.09, 95% CI 1.03-1.15, p = 0.002). Compared to the low MgDS group, individuals in the middle MgDS group had 17% higher odds of OAB (OR = 1.17, 95% CI 1.03-1.33, p = 0.02), while those in the high MgDS group had 20% higher odds (OR = 1.20, 95% CI 1.05-1.38, p = 0.01). Subgroup analyses indicated that this association was particularly pronounced in females, non-smokers, middle-aged adults (40-60 years), and individuals with obesity (BMI ≥ 30 kg/m
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.